Press release
Key Trend Reshaping the Osteoporosis Drugs Market in 2025: Innovative Solutions In Osteoporosis Treatment With Teriparatide Injectable For Affordable And Convenient Patient Care
Osteoporosis Drugs Market Size
The osteoporosis drug market is anticipated to be driven by a growing occurrence of osteoporosis. This bone disease, which is marked by decreased bone mineral density, change in bone quality or structure or decline in mass bone, typically affects people who intake lesser quantities of calcium. These drugs designed to combat osteoporosis work by increasing the bone mineral density and reducing the risk of fractures. As per data from the Australian Institute of Health and Welfare Australia-Government agency in June 2024, osteoporosis was the cause for 2,659 deaths or 10.2 deaths per 100,000 population in 2022, equating to 1.4% of total deaths. Hence, the rising incidence of osteoporosis is fuelling the expansion of the market for osteoporosis drugs.
Get Your Osteoporosis Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report
What Is the projected market size and growth rate for the osteoporosis drugs market?
The market size of osteoporosis medications has consistently shown growth in the last few years. The market value is predicted to rise from $12.33 billion in 2024 up to $12.8 billion in 2025, reflecting a compound annual growth rate (CAGR) of 3.8%. The growth witnessed in the historic period can be tied to factors such as an aging population, rising awareness, increased diagnoses, lifestyle influences, government-driven initiatives, and healthcare policies.
The market size of osteoporosis medications is anticipated to maintain consistent growth in the forthcoming years, reaching an estimated value of $14.48 billion by 2029, with a compound annual growth rate of 3.1%. This prediction can be credited to factors such as the aging population trend, improvements in treatment choices, heightened emphasis on male bone health, patient learning and empowerment, universal health policies, and insurance protection. Futuristic tendencies for this period point towards personalized medical treatment, the pursuit of combination treatments, emphasis on strategies to prevent fractures, investment in R&D for innovative drug targets, and collaborations centered around drug development.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9102&type=smp
How are the latest trends influencing the growth of the osteoporosis drugs market?
Leading firms within the osteoporosis medication sector have shown progress towards adopting novel solutions. For example, Apotex Inc., a Canadian pharmaceutical firm, unveiled their Teriparatide Injectable for Osteoporosis Treatment in November 2023. This product is a prefilled injectable pen with 250 mcg/mL of teriparatide, capable of delivering 28 daily dosages of 20 mcg. It's designed for solitary patient usage, offering individuals suffering from osteoporosis an accessible and affordable treatment option.
What are the major segments of the osteoporosis drugs market and their role in driving growth?
The osteoporosis drugs market covered in this report is segmented -
1) By Type: Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors
2) By Administration: Oral, Injectable
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Sales
4) By Application: Primary Osteoporosis, Secondary Osteoporosis
Subsegments:
1) By Bisphosphonates: Alendronate, Risedronate, Ibandronate, Zoledronic Acid
2) By Selective Estrogen Receptor Modulators (SERMs): Raloxifene, Bazedoxifene
3) By RANK Ligand Inhibitors: Denosumab
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9102
Which regions are key players in the growth of the osteoporosis drugs market?
North America was the largest region in the osteoporosis market in 2024. The regions covered in the osteoporosis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the osteoporosis drugs market?
Major companies operating in the osteoporosis drugs market include Pfizer Inc., F. Hoffmann La Roche Ltd., Merck & Co Inc., Novartis AG, Bristol Myers Squibb Company, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Asahi Kasei Pharma Corporation, Viatris Inc., Teva Pharmaceutical Industries Ltd, Mylan N.V., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Ipsen, Kyowa Kirin Co Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Recordati S.p.A., Cadila Healthcare Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Sunovion Pharmaceuticals Inc., Theramex, Radius Health Inc., Strides Pharma Science Limited, Apotex Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=9102&type=smp
What Is Covered In The Osteoporosis Drugs Global Market Report?
•Market Size Forecast: Examine the osteoporosis drugs market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the osteoporosis drugs market for a structured understanding.
•Key Players Overview: Analyze major players in the osteoporosis drugs market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the osteoporosis drugs market.
•Segment Contributions: Evaluate how different segments drive overall growth in the osteoporosis drugs market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the osteoporosis drugs market.
•Industry Challenges: Identify potential risks and obstacles affecting the osteoporosis drugs market.
•Competitive Landscape: Review strategic developments in the osteoporosis drugs market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Trend Reshaping the Osteoporosis Drugs Market in 2025: Innovative Solutions In Osteoporosis Treatment With Teriparatide Injectable For Affordable And Convenient Patient Care here
News-ID: 3911849 • Views: …
More Releases from The Business Research Company
Emerging Trends to Reshape the Surgical Energy Instruments Market: Innovative Te …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Surgical Energy Instruments Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the past few years, the market size of surgical energy instruments has seen substantial growth. The market which is projected to be worth $4.68 billion in 2024, is expected to inflate to $5.2…
2025-2034 Spatial omics Market Evolution: Disruptions, Innovations, and Untapped …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Spatial omics Market Through 2025?
In recent years, the size of the spatial omics market has seen rapid expansion. The estimations show an increase to $0.33 billion in 2025 from $0.3 billion in 2024, marking a compound annual growth rate (CAGR) of…
Global Sigmoidoscope Market Projected to Grow at 6.1% CAGR, Reaching $3.38 Billi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Sigmoidoscope Industry Market Size Be by 2025?
In recent years, there has been a significant increase in the size of the sigmoidoscope market. The market is projected to expand from $2.53 billion in 2024 to $2.67 billion in 2025, demonstrating a compound annual growth rate (CAGR)…
2025-2034 Refurbished MRI Systems Market Roadmap: Insights for Competitive Advan …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Refurbished MRI Systems Market Size By 2025?
The market size for refurbished MRI systems has experienced robust growth in the past few years. It is expected to rise from $0.77 billion in 2024 to $0.85 billion in 2025, showcasing a compound annual growth rate (CAGR)…
More Releases for Osteoporosis
Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: …
The Osteoporosis Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period?
The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024…
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate?
The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected…
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss.
View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market
The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of…
Osteoporosis Drugs: The Complete Review
Medication for osteoporosis increases bone mineral density and reduces fracture risk. Some osteoporosis medications promote bone growth while others reduce bone loss.
The bones may begin to deteriorate as age more quickly than the body can heal them. The doctor could determine that people have osteoporosis if they have significant bone density loss.
To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market/report-sample
Although osteoporosis cannot be treated, it can be slowed down or…
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related…
